18F-FDG PET for the evaluation of thymic epithelial tumors: Correlation with the World Health Organization classification in addition to dual-time-point imaging

Akira Inoue1, Noriyuki Tomiyama2, Mitsuaki Tatsumi1, Naoki Ikeda3, Meinoshin Okumura3, Hiroshi Shiono3, Masayoshi Inoue3, Ichiro Higuchi1, Katsuyuki Aozasa4, Takeshi Johkoh2, Hajime Nakamura2, Jun Hatazawa1
1Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
2Department of Radiology, Osaka University Graduate School of Medicine, Osaka, Japan
3Department of Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
4Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Rosai J, Sobin LH. Histological typing of tumours of the thymus: international histological classification of tumours. 2nd ed. New York: Springer; 1999.

Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. World Health Organization classification of tumors: Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004.

Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, et al. The World Health Organization histologic classification system reflects the oncological behavior of thymoma: a clinical study of 273 patients. Cancer 2002;94:624–32.

Chen G, Marx A, Wen-Hu C, Yong J, Puppe B, Stroebel P, et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 2002;95:420–9.

Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485–92.

Okumura M, Miyoshi S, Fujii Y, Takeuchi Y, Shiono H, Inoue M, et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of consecutive 146 tumors. Am J Surg Pathol 2001;25:103–10.

Tomiyama N, Müller NL, Ellis SJ, Cleverley JR, Okumura M, Miyoshi S, et al. Invasive and non-invasive thymoma: distinctive CT features. J Comput Assist Tomogr 2001;25:388–93.

Jung KJ, Lee KS, Han J, Kim J, Kim TS, Kim EA. Malignant thymic epithelial tumors: CT-pathologic correlation. AJR Am J Roentgenol 2001;176:433–9.

Tomiyama N, Johkoh T, Mihara N, Honda O, Kozuka T, Koyama M, et al. Using the World Health Organization classification of thymic epithelial neoplasms to describe CT findings. AJR Am J Roentgenol 2002;179:881–6.

Han J, Lee KS, Yi CA, Kim TS, Shim YA, Kim J, et al. Thymic epithelial tumors classified according to a newly established WHO scheme: CT and MR findings. Korean J Radiol 2003;4:46–53.

Jeong YJ, Lee KS, Kim J, Shim YM, Jan J, Kwon OJ. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis. AJR Am J Roentgenol 2004;183:283–9.

Inoue A, Tomiyama N, Fujimoto K, Sadohara J, Nakamichi I, Tomita Y, et al. MR imaging of thymic epithelial tumors: correlation with World Health Organization classification. Radiat Med 2006;24:171–81.

Smith CS, Schöder H, Yeung HW. Thymic extension in the superior mediastinum in patients with thymic hyperplasia: potential cause of false-positive findings on 18F-FDG PET/CT. AJR Am J Roentgenol 2007;188:1716–21.

Ferdinand B, Gupta P, Kramer EL. Spectrum of thymic uptake at 18F-FDG PET. Radiographics 2004;24:1611–6.

Patel PM, Alibazoglu H, Ali A, Fordham E, LaMonica G. Normal thymic uptake of FDG on PET imaging. Clin Nucl Med 1996;21:772–5.

Sasaki M, Kuwabara Y, Ichiya Y, Akashi Y, Yoshida T, Nakagawa M, et al. Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET. J Nucl Med 1999;40:1595–601.

Sung YM, Lee KS, Kim BT, Choi JY, Shim YM, Yi CA. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med 2006;47:1628–34.

Minn H, Clavo AC, Grénman R, Wahl RL. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 1995;36:252–8.

Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med 2001;28:696–703.

Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001;42:1412–7.

Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med 2003;44:540–8.